Creating a Future for Regenerative Medicine

Oct. 31, 2024IR News

Released the Summary of Financial Results for the 2nd Quarter of FY2024
Oct. 1, 2024News Release

Announcement of NHI Listing of Autologous Cultured Epidermis Maintaining Melanocytes “JACEMIN” for the Treatment of Vitiligo
Sep. 18, 2024Columns / Topics

Participated in EUROTOX 2024
Sep. 17, 2024News Release

Announcement on the Progress of the Clinical Trial of Allogeneic Cultured Epidermis Allo-JaCE03
Sep. 5, 2024News Release

The In Vitro Skin Sensitization Test Method EpiSensA Using the Human 3-Dimensional Cultured Tissue Model LabCyte EPI-MODEL24 Becomes an International Standard

Columns & Topics

Sep. 18, 2024[EVENT]

Participated in EUROTOX 2024

Apr. 18, 2024[INSIDE REGENERATIVE MEDICINE]

Wonderful Reward

Jun. 19, 2023[PICK UP]

Tales of Regenerative Medicine Vol.9 & 10

Mar. 22, 2023[INSIDE REGENERATIVE MEDICINE]

Our Company’s Assets

Jan. 10, 2023[INSIDE REGENERATIVE MEDICINE]

New Year’s Greeting

Nov. 1, 2022[INSIDE REGENERATIVE MEDICINE]

Thinking About the Kashiwa-no-ha “Regenerative Medicine Platform”

See More Columns & Topics

For Customers

For
Patients and their Families

Regenerative Medicine
Developers

Cultured Human
Tissue Users

J-TEC's
Ethics Committee